MSc Biotherapeutics will provide the theoretical background, practical training and ancillary workplace skills that will equip graduates with the essential tools for a successful career in the biopharmaceutical and biotechnology industry both in Ireland and abroad.

• Expert faculty and senior industry practitioners working at the forefront of their disciplines
• Hands-on practical experience in bioprocessing
• Large research component in hi-tech research lab
• Company visits and access to The National Institute for Bioprocessing Research and Training (NIBRT) on campus

Course Description

This programme will provide students with a comprehensive understanding of the development of biotherapeutics, beginning with pre-clinical modelling and target identification together with antibody engineering, biochemical and biophysical characterisation, and development issues for bioprocessing. Systems biology of biotechnological processes and approaches to the analysis of proteomics based discovery data will be covered in detail together with mathematical modelling, bioinformatics analysis and data integration strategies. Regulatory issues, and innovation and commercialisation strategies, will also be covered. Mammalian cell culture and bioprocess laboratory structure will be comprehensively covered in addition to novel approaches to therapeutic development. A practical drug discovery laboratory project will form a significant component of the experience of how candidates are identified and brought through the development pipeline.

What modules can I take?

The programme consists of lectures, tutorials, seminars, workshops, case studies and a large research module. To complete the MSc in Biotherapeutics you must complete 90 credits of modules including a substantial lab-based project.

Careers & Employability

This programme will enable you to choose from a wide range of careers and areas of postgraduate study. This multi-disciplinary course provides a solid grounding for careers in industry, health and research.

Prospective Employers

Prospective employers include: Novartis, Glaxo SmithKline, Eli Lily, Johnson & Johnson, Pfizer, Janssen Biologies, AstraZeneca, MSD, Bristol Myers Squibb, Abbott, Sanofi, Seroba Kernel, Dignity Science, Quintiles.

Programme Outcomes

• Students will be able to analyse, evaluate and communicate biotherapeutics research
• Students will be able to comprehend the challenges of scaling bioprocesses and apply their knowledge to overcome these
• Students will be able to demonstrate a comprehensive understanding of the principles and applications of biotherapeutics
• Students will be able to develop a professional approach to engaging with industry and an applied methodology in preparing for employment opportunities
• Students will be able to develop effective time management, problem solving and reporting skills as required in a professional workplace
• Students will be able to work safely and effectively in a biotherapeutics laboratory, both independently and as part of a team